BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17881008)

  • 1. Bv8/Prokineticin proteins and their receptors.
    Negri L; Lattanzi R; Giannini E; Melchiorri P
    Life Sci; 2007 Sep; 81(14):1103-16. PubMed ID: 17881008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prokineticins: a novel pair of regulatory peptides.
    Zhou QY
    Mol Interv; 2006 Dec; 6(6):330-8. PubMed ID: 17200460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: Localization of Bv8 receptors to endothelial cells.
    LeCouter J; Lin R; Tejada M; Frantz G; Peale F; Hillan KJ; Ferrara N
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2685-90. PubMed ID: 12604792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity.
    Monnier C; Dodé C; Fabre L; Teixeira L; Labesse G; Pin JP; Hardelin JP; Rondard P
    Hum Mol Genet; 2009 Jan; 18(1):75-81. PubMed ID: 18826963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling role of prokineticin 2 on the estrous cycle of female mice.
    Xiao L; Zhang C; Li X; Gong S; Hu R; Balasubramanian R; Crowley W WF; Hastings MH; Zhou QY
    PLoS One; 2014; 9(3):e90860. PubMed ID: 24633064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Potential of Targeting Prokineticin Receptors in Diseases.
    Vincenzi M; Kremić A; Jouve A; Lattanzi R; Miele R; Benharouga M; Alfaidy N; Migrenne-Li S; Kanthasamy AG; Porcionatto M; Ferrara N; Tetko IV; Désaubry L; Nebigil CG
    Pharmacol Rev; 2023 Nov; 75(6):1167-1199. PubMed ID: 37684054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prokineticin signaling in heart-brain developmental axis: Therapeutic options for heart and brain injuries.
    Désaubry L; Kanthasamy AG; Nebigil CG
    Pharmacol Res; 2020 Oct; 160():105190. PubMed ID: 32937177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bv8-prokineticins and their receptors: modulators of pain.
    Negri L; Lattanzi R
    Curr Pharm Biotechnol; 2011 Oct; 12(10):1720-7. PubMed ID: 21466441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the Prokineticin System to Control Chronic Pain and Inflammation.
    Negri L; Maftei D
    Curr Med Chem; 2018; 25(32):3883-3894. PubMed ID: 28707588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prokineticin 2 is a catabolic regulator of osteoarthritic cartilage destruction in mouse.
    Yang J; Shin Y; Kim HJ; Kim HE; Chun JS
    Arthritis Res Ther; 2023 Dec; 25(1):236. PubMed ID: 38057865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Prokineticins on Cerebral Cell Function and Blood-Brain Barrier Permeability.
    Younes H; Kyritsi I; Mahrougui Z; Benharouga M; Alfaidy N; Marquette C
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: Neuropeptide GPCRs in neuroendocrinology, Volume II.
    Vaudry H; Schoofs L; Civelli O; Kojima M
    Front Endocrinol (Lausanne); 2023; 14():1219530. PubMed ID: 37415662
    [No Abstract]   [Full Text] [Related]  

  • 13. Prokineticin 2/PROK2 and Male Infertility.
    Petrella C; Spaziani M; D'Orazi V; Tarani L; Terracina S; Tarani F; Micangeli G; Barbato C; Minni A; Greco A; Isidori AM; Ferraguti G; Fiore M
    Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data.
    Zhong J; Xiang D; Ma X
    Biomed Res Int; 2022; 2022():2309339. PubMed ID: 35845958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protective effect of chemical and natural compounds against vincristine-induced peripheral neuropathy (VIPN).
    Khodaei M; Mehri S; Pour SR; Mahdavi S; Yarmohammadi F; Hayes AW; Karimi G
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Aug; 395(8):907-919. PubMed ID: 35562512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of prokineticin 2 and its receptor in endometrium of recurrent implantation failure patients decreased the expression of MMP9 important for decidualization.
    Zhai J; Ma L; Chang Z; Yu T
    Reprod Biol Endocrinol; 2022 May; 20(1):76. PubMed ID: 35501804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prokineticin-Receptor Network: Mechanisms of Regulation.
    Lattanzi R; Miele R
    Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and Functional Diversity of Animal Toxins Interacting With GPCRs.
    Van Baelen AC; Robin P; Kessler P; Maïga A; Gilles N; Servent D
    Front Mol Biosci; 2022; 9():811365. PubMed ID: 35198603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic factors as prognostic markers in neuroendocrine neoplasms.
    Puliani G; Sesti F; Anastasi E; Verrico M; Tarsitano MG; Feola T; Campolo F; Di Gioia CRT; Venneri MA; Angeloni A; Appetecchia M; Lenzi A; Isidori AM; Faggiano A; Giannetta E;
    Endocrine; 2022 Apr; 76(1):208-217. PubMed ID: 35088292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis.
    Noda K; Dufner B; Ito H; Yoshida K; Balboni G; Straub RH
    Sci Rep; 2021 Sep; 11(1):18399. PubMed ID: 34526577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.